FRP sheets wrapped specimen. by Qingwen Li (1510687)

Subjects:

The schematic of the mechanism of action. by Qingwen Li (1510687)

Subjects:

Coal gangue concrete specimens. by Qingwen Li (1510687)

Subjects:

Elastic modulus of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

GFRP confined concrete specimens. by Qingwen Li (1510687)

Subjects:

13 Compressive strength of FRP confined CGC. by Qingwen Li (1510687)

Subjects:

VANGL2 recruits NLRP3 to OPTN for selective autophagic degradation. by Huaji Jiang (16907514)

Patient status overview. by Farayi Kaseke (19560197)

Subjects:

The comparison of the Spectral Exponent in hemispherotomy with a reference pediatric sample across wakefulness and NREM Sleep reveal values compatible with deep sleep in the isolat... by Michele Angelo Colombo (22446342)

Subjects:

Group-level narrow- and broad-band spectral changes after hemispherotomy reveal a marked EEG slowing of the isolated cortex, robust across patients. by Michele Angelo Colombo (22446342)

Subjects:

Dataset (Figs 2–5). by Xianyong Wang (22601067)

“…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …”

Schematic diagram of soil sample collection. by Xianyong Wang (22601067)

“…Results indicated that high fertilizer treatments significantly increased short-term soil N, P, and K availability; however, their concentrations decreased by day 10 post-application, indicating the necessity for topdressing at 10-day intervals to maintain nutrient effectiveness. …”

This is the data set that we used to reach the conclusions drawn in the manuscript with related metadata and methods. by Farayi Kaseke (19560197)

Subjects:

Boxplots of morphological parameters between racial groups. by Zoë Dinkel (21402766)

Subjects:

Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

Subjects:

The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

Subjects:

Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

Subjects:

Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

Subjects:

Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

Subjects:

The original data for the figures. by Masashi Okawa (8951294)

Subjects: